Iradimed (IRMD) Net Shares Issued and Repurchased (2014 - 2025)
Iradimed's (IRMD) quarterly Net Shares Issued and Repurchased came in at $6559.0 in Q4 2025, up 109.55% year-over-year from $3130.0 in Q4 2024, and up 109.55% quarter-over-quarter from $3130.0 in Q4 2024.
Powered by 
Analysis
Iradimed (IRMD) Net Shares Issued and Repurchased (2014 - 2025) Analysis & Trends
Iradimed (IRMD) has reported Net Shares Issued and Repurchased for 12 consecutive years, with $6559.0 the latest figure, recorded in Q4 2025.
- On a quarterly basis, Net Shares Issued and Repurchased rose 109.55% year-over-year to $6559.0 in Q4 2025; TTM through Dec 2025 was $6559.0, a 109.55% increase from a year earlier, with the FY2025 full-year figure at $6559.0, up 109.55% from the prior year.
- Net Shares Issued and Repurchased was $6559.0 for Q4 2025 at Iradimed, up from $3130.0 in the prior quarter.
- Over five years, Net Shares Issued and Repurchased peaked at $9346.0 in Q1 2021 and troughed at $881.0 in Q1 2024.
- A 5-year average of $4111.8 and a median of $3393.0 in 2023 frame the typical range for Net Shares Issued and Repurchased.
- Across the five-year window, Net Shares Issued and Repurchased sank 88.24% in 2022 and jumped 232.67% in 2023, its largest moves.
- Over 5 years, Net Shares Issued and Repurchased stood at $9346.0 in 2021, then slumped by 88.24% to $1099.0 in 2022, then jumped by 232.67% to $3656.0 in 2023, then retreated by 14.39% to $3130.0 in 2024, then soared by 109.55% to $6559.0 in 2025.
- The last three Net Shares Issued and Repurchased figures came in at $6559.0 (Q4 2025), $3130.0 (Q4 2024), and $881.0 (Q1 2024), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Shares Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | - |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | - |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | - |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | - |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | - |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | - |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | - |
| 10 | Iradimed | 1.07 Bn | 1.01 Bn | 15.16 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 6,559.00 |
| Dec 31, 2024 | 3,130.00 |
| Mar 31, 2024 | 881.00 |
| Mar 31, 2023 | 3,656.00 |
| Mar 31, 2022 | 1,099.00 |
| Mar 31, 2021 | 9,346.00 |
| Mar 31, 2020 | 25,724.00 |
| Dec 31, 2019 | 50,000.00 |
| Mar 31, 2019 | 11,270.00 |
| Mar 31, 2018 | 1,933.00 |
| Dec 31, 2017 | 12,438.00 |
| Mar 31, 2017 | 3,500.00 |
| Dec 31, 2016 | 59,375.00 |
| Mar 31, 2016 | 24,000.00 |
| Dec 31, 2015 | 38,000.00 |
| Mar 31, 2015 | 24,000.00 |
| Dec 31, 2014 | 281,750.00 |